TAK 653Alternative Names: TAK-653
Latest Information Update: 05 Oct 2015
At a glance
- Originator Takeda
- Class Antidepressants
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Depressive disorders
Most Recent Events
- 01 Sep 2015 Phase-I clinical trials in Depressive disorders (In volunteers) in United Kingdom (PO) (NCT02561156)